검색어 : 통합검색[315.2]
총 3,625건 중 1,000건 출력
, 21/100 페이지
-
201
- The Anglo-Japanese Alliance. By Chung-fu Chang. (Baltimore: The Johns Hopkins Press, 1931. pp. x, 315. Index. $2.75.)
- Dennett, Tyler; ; (The American journal of international law, v.26, 1932, pp.458-458)
-
202
- Studies on the Physical Dependence of A New Central Analgesic; 1-(m-Methoxyphenyl)-2-Dimethylaminomethyl Cyclohexanol (1) HCL (CG-315)
- YAMAMOTO, Hiroyuki; HAYANO, Taizo; MASUDA, Yasusuke; MURANO, Tadashi; ; (The Japanese journal of pharmacology : official publication of the Japanese Pharmacological Society, v.22, 1972, pp.715-720)
-
203
- Fluorescence excitation spectra, lifetimes, and quenching of S2(<i>B</i> 3Σ<i>u</i>−) in the wavelength region 280-315 nm
- Quick Jr., C. R.; Weston Jr., Ralph E.; Department of Chemistry, Brookhaven National Laboratory, Upton, New York 11973; Department of Chemistry, Brookhaven National Laboratory, Upton, New York 11973; (The Journal of chemical physics, v.74, 1981, pp.4951-4959)
-
204
- Abstract 5994: INX-315, a potent and selective CDK2 inhibitor, demonstrates robust antitumor activity in <i>CCNE1</i>-amplified cancers
- Trub, Alec G.; Bisi, John E.; Dietrich, Catherine; Taylor, Michael; Strum, Jay C.; Goel, Shom; Roberts, Patrick J.; 1Incyclix Bio, Durham, NC; ; 1Incyclix Bio, Durham, NC; ; 2Peter MacCallum Cancer Centrer, Melbourne, Australia.; 2Peter MacCallum Cancer Centrer, Melbourne, Australia.; 1Incyclix Bio, Durham, NC; ; 2Peter MacCallum Cancer Centrer, Melbourne, Australia.; 1Incyclix Bio, Durham, NC; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.83, 2023, pp.5994-5994)
-
205
- Overcoming Bcr-Abl T315I mutation by combination of GNF-2 and ATP competitors in an Abl-independent mechanism
- Khateb, Mamduh; Ruimi, Nili; Khamisie, Hazem; Najajreh, Yousef; Mian, Afsar; Metodieva, Anna; Ruthardt, Martin; Mahajna, Jamal; Cancer Drug Discovery Program, Galilee Technology Center, Migal, P.O.Box 831, Kiryat Shmona, 11016, Israel; Cancer Drug Discovery Program, Galilee Technology Center, Migal, P.O.Box 831, Kiryat Shmona, 11016, Israel; Cancer Drug Discovery Program, Galilee Technology Center, Migal, P.O.Box 831, Kiryat Shmona, 11016, Israel; Faculty of Pharmacy, Al-Quds University, Jerusalem-Abu Dies, Palestine; Medizinische Klinik II/Abt. Hä matologie, Klinikum der Goethe-Universitä t, Theodor-Stern Kai 7, 60590, Frankfurt, Germany; Medizinische Klinik II/Abt. Hä matologie, Klinikum der Goethe-Universitä t, Theodor-Stern Kai 7, 60590, Frankfurt, Germany; Medizinische Klinik II/Abt. Hä matologie, Klinikum der Goethe-Universitä t, Theodor-Stern Kai 7, 60590, Frankfurt, Germany; Cancer Drug Discovery Program, Galilee Technology Center, Migal, P.O.Box 831, Kiryat Shmona, 11016, Israel; (BMC cancer, v.12, 2012, pp.563-563)
-
206
- Anti‐PD‐1/Her2 Bispecific Antibody IBI315 Enhances the Treatment Effect of Her2‐Positive Gastric Cancer through Gasdermin B‐Cleavage Induced Pyroptosis
- Lin, Wu; Zhang, Yingzi; Yang, Yan; Lin, Ben; Zhu, Mengjia; Xu, Jinling; Chen, YiRan; Wu, Weiwei; Chen, Bingliang; Chen, Xiangliu; Liu, Jin; Wang, Haohao; Teng, Fei; Yu, Xiongfei; Wang, Haiyong; Lu, Jun; Zhou, Quan; Teng, Lisong; Department of Surgical Oncology The First Affiliated Hospital Zhejiang University School of Medicine Hangzhou Zhejiang 310003 China; Department of Surgical Oncology The First Affiliated Hospital Zhejiang University School of Medicine Hangzhou Zhejiang 310003 China; Department of Surgical Oncology The First Affiliated Hospital Zhejiang University School of Medicine Hangzhou Zhejiang 310003 China; College of Medicine Jiaxing University Jiaxing Zhejiang 314001 China; Department of Drug Discovery Innovent Biologics (Suzhou) Co. Suzhou Jiangsu 215000 China; Department of Drug Discovery Innovent Biologics (Suzhou) Co. Suzhou Jiangsu 215000 China; Department of Surgical Oncology The First Affiliated Hospital Zhejiang University School of Medicine Hangzhou Zhejiang 310003 China; Department of Drug Discovery; (Advanced science, v.10, 2023, pp.2303908)
-
207
- 315.1: 5-HT2 and 5-HT2B Receptor Antagonism Abrogates Fibrotic Potential of Human Renal Allograft Fibroblasts by Targeting STAT3 Pathway
- Jaiswal, Akhilesh; Prasad, Narayan; Chaturvedi, Saurabh; Agarwal, Vikas; Singh, Mantabya; Rai, Mohit; Nephrology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India; Nephrology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India; Pharmacy, Ganesh Shankar Vidyarthi Memorial Medical College, Kanpur, India.; Clinical Immunology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India; Nephrology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India; Clinical Immunology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India; (Transplantation, v.106, 2022, pp.S233-S233)
-
208
- Corrigendum to the graphical abstract of “A concise synthesis of methyl 2,6-dideoxy-2-fluoro-β-<SMALL>L</SMALL>-talopyranoside” : [Carbohydrate Research 315 (1999) 187–191]
- Todd Deal, S.; Horton, Derek; ; (Carbohydrate research, v.320, 1999, pp.143-143)
-
209
- Book Review: Jan G. Van der Watt (ed.), <I>Eschatology of the New Testament and Some Related Documents</I>, WUNT 2.315
- Foster, Paul; ; (The Expository times, v.124, 2013, pp.517-517)
-
210
- Motor Impairments in Transient Ischemic Attack and Subsequent Stroke : 2795 Board #315 June 2 9 30 AM - 11 00 AM
- Lodha, Neha; Harrell, Jane; Eisenschenk, Stephan; Christou, Evangelos; ; (Medicine and science in sports and exercise, v.49, 2017, pp.804)
QUICK MENU
